TETmedical, Inc.

📍 Ithaca, United States🗓 Founded 2021👥 13 employees💰 Last funded 2025
Medical and Diagnostic Laboratories🌐 tetmedical.com
Website LinkedIn
TETmedical, Inc. (Tethered Enzyme Technologies) is a clinical stage platform nanomedicine company focused on in vitro diagnostics that enable insights for high-consequence disease decision making. TET emerged out of groundbreaking innovations originating at Cornell University. Our device measures less than a hundredth the width of a human hair. It is a miniature, functioning, highly stable molecular machine, capable of performing chemical operations with high sensitivity, stability, and speed (thousands of times faster than antibody assays): a patented “TET nanobot”, consisting of thousands of enzymes tethered to a silica nanoparticle. TETmedical’s first product is the NSE-FAST (Neuron Specific Enolase Functional Activity Stroke Test), the first in-vitro diagnostic for brain injury from stroke.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in TETmedical, Inc.?
TETmedical, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did TETmedical, Inc. last raise funding?
The most recent investment in TETmedical, Inc. recorded on gritt.io was in 2025.
When was TETmedical, Inc. founded?
TETmedical, Inc. was founded in 2021.
What industry is TETmedical, Inc. in?
TETmedical, Inc. operates in Medical and Diagnostic Laboratories. Find similar Medical and Diagnostic Laboratories investors on gritt.io.
Where is TETmedical, Inc. based?
TETmedical, Inc. is headquartered in Ithaca, United States.